$NKTR
Nektar Therapeutics
XNAS•Health Care•Pharmaceutical Preparations
$38.21
▲+1.19%+$0.450Market open
Nektar Therapeutics
XNAS•Health Care•Pharmaceutical Preparations
Why is NKTR up today? It is at $38.21 (+1.19%), and our scanner flagged it 102 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NKTR spikes, and full due diligence on NKTR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NKTR 102 times in the last 30 days. Create a free account to track $NKTR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
NKTR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on NKTR today, peaking at 3.7x its normal volume.
Likely catalystData Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026, from an SEC filing. Read it →Latest filingS-8Registration statementOct 19, 2026 · 15 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
1,762,839 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $150.0M in size · Priced at $85.09/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ajer Jeffrey Robert Director | Acquired (grant/award) | +2K | added 88% | 4K | n/a | Sep 23, 26 |
Brainard Diana Director | Acquired (grant/award) | +2K | added 100% | 4K | n/a | Sep 23, 26 |
Chess Robert Director | Acquired (grant/award) | +2K | added 12% | 19K | n/a | Sep 23, 26 |
Greer R Scott Director | Acquired (grant/award) | +2K | added 9.9% | 22K | n/a | Sep 23, 26 |
Whitfield Roy A Director | Acquired (grant/award) | +2K | added 14% | 16K | n/a | Sep 23, 26 |
Robin Howard W Officer | Sold (automatic/other) | -418 | sold 0.8% | 55K | $30K at $71.98 | Aug 18, 26 |
Zalevsky Jonathan Officer | Sold (automatic/other) | -186 | sold 1.9% | 10K | $13K at $71.98 | Aug 18, 26 |
Zalevsky Jonathan Officer | Sold (automatic/other) | -6K 0.02% of company | sold 37% | 10K | $398K at $70.00 | Jun 30, 26 |
Robin Howard W Officer | Sold (automatic/other) | -10K 0.03% of company | sold 15% | 55K | $608K at $60.81 | Jun 17, 26 |
Robin Howard W Officer | Sold (automatic/other) | -10K 0.03% of company | sold 13% | 65K | $600K at $59.97 | Jun 16, 26 |
Zalevsky Jonathan Officer | Sold (automatic/other) | -6K 0.02% of company | sold 26% | 15K | $336K at $60.71 | Jun 15, 26 |
Robin Howard W Officer | Sold (automatic/other) | -444 | sold 0.6% | 75K | $29K at $65.51 | May 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
NKTR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on NKTR today, peaking at 3.7x its normal volume.
NKTR last traded at $38.21, up 1.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nektar Therapeutics (NKTR) is next expected to report earnings on Thursday, November 12, 2026 (after close), about 8 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NKTR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NKTR 102 times in the last 30 days.
NKTR (Nektar Therapeutics) trades on XNAS, with a market cap of about $1.29B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NKTR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NKTR discussion
Sign in to ask a question or join the discussion.